Drug Registration and Acceptance

Drug Name

Exact

Active Ingredient

Acceptance No.

Manufacturers

Acceptance Date

Status Date

Classification

Review Status

Drug Type

Submission

Evaluation Conclusion

ATC Category

Special Approval Varieties

Task Type

Major Special Varieties

Sequence No.

Stock Code

Visualized Analysis Export Evaluation Conclusion Evaluation Progress

Acceptance No.	Drug Name	Active Ingredient	Dosage Form	Classification	Submission	Acceptance Date	Manufacturers	Manufacturers	Review Status	Status Date	View
CXSL1700106	注射用重组人血白蛋白-生长激素融合蛋白	Recombinant Human Serum Albumin-Human Growth Hormone Fusion Protein	Lyophilized	Biological Products(1)	New Drug Application	2017-11-16	浙江优诺金生物工程有限公司	Zhejiang Younuojin Bioengineering Co Ltd	In Review	2017-11-14	view
CXSL1500014	重组人血白蛋白		Excipients	Biological Products(11)	New Drug Application	2015-04-30	浙江海正药业股份有限公司	Zhejiang Hisun Pharmaceutical Co Ltd	Certificate Issued	2017-06-20	view
CXFL1500001	重组人血白蛋白		Excipients	Other	New Drug Application	2015-04-21	浙江海正药业股份有限公司	Zhejiang Hisun Pharmaceutical Co Ltd	In Review	2015-04-16	view
JXFL1400020	重组人血白蛋白		Excipients	Other	Import Drug Application	2014-08-07	诺维信生物医药英国有限公司	Novozymes Biopharma UK Ltd	In Review	2014-08-06	view
CXFL1300001	重组人血白蛋白		Excipients	Other	New Drug Application	2013-06-18	浙江海正药业股份有限公司	Zhejiang Hisun Pharmaceutical Co Ltd	Certificate Issued	2013-12-02	view
CXSL1200098	重组人血白蛋白		Excipients	Biological Products(11)	New Drug Application	2013-06-18	浙江海正药业股份有限公司	Zhejiang Hisun Pharmaceutical Co Ltd	Certificate Issued	2013-12-02	view
CXFL0900003	重组人血白蛋白		Excipients	Other	New Drug Application	2010-01-28	华北制药股份有限公司	North China Pharmaceutical CompanyLtd	Certificate Issued	2011-02-21	view
CXFL0900002	重组人血白蛋白		Excipients	Other	New Drug Application	2010-01-28	华北制药股份有限公司	North China Pharmaceutical CompanyLtd	Certificate Issued	2011-02-21	view